← Back to guidelines
Cardiology34 papers

Systolic heart failure

Last edited: 4/22/2026

Overview

Systolic heart failure is characterized by the heart's reduced ability to pump adequate blood flow to meet the body's needs, primarily due to impaired left ventricular systolic function 1.

Diagnosis

  • Key Diagnostic Criteria: Reduced left ventricular ejection fraction (LVEF <50%), symptoms of dyspnea, fatigue, and exercise intolerance 1.
  • Recommended Tests: Echocardiography for LVEF measurement, natriuretic peptide levels (BNP/NT-proBNP) 1.
  • Orthostatic Hypotension Assessment: Evaluate for exaggerated orthostatic blood pressure fall (systolic drop ≥20 mmHg) in older patients 2.
  • Management

  • First-Line Treatments:
  • - Angiotensin-Converting Enzyme Inhibitors (ACE inhibitors) or Angiotensin Receptor Blockers (ARBs) to reduce morbidity and mortality 1. - Beta-Blockers to improve survival and reduce hospitalizations 1.
  • Adjunctive Therapies:
  • - Diuretics for managing fluid retention and reducing symptoms 1. - Surgical Modulation: Consider carotid body resection for sympathetic modulation in selected cases to decrease sympathetic tone 1.

    Special Populations

  • Elderly:
  • - Monitor for cerebral blood flow changes during diuretic therapy; generally, cerebral perfusion appears preserved despite BP reduction 3. - Caution with orthostatic hypotension, particularly in older patients with isolated systolic hypertension 2.

    Key Recommendations

  • Implement ACE inhibitors or ARBs as first-line therapy to improve outcomes in systolic heart failure (Evidence: Strong 1).
  • Incorporate beta-blockers into treatment regimens to enhance survival and reduce hospitalizations (Evidence: Strong 1).
  • Evaluate and manage orthostatic hypotension in older patients with systolic heart failure due to its prevalence and potential impact (Evidence: Moderate 2).
  • Consider carotid body resection as a novel approach for sympathetic modulation in carefully selected patients, though evidence is preliminary (Evidence: Weak 1).
  • References

    1 Niewinski P, Janczak D, Rucinski A, Tubek S, Engelman ZJ, Piesiak P et al.. Carotid body resection for sympathetic modulation in systolic heart failure: results from first-in-man study. European journal of heart failure 2017. link 2 Vanhanen H, Thijs L, Birkenhäger W, Bulpitt C, Tilvis R, Sarti C et al.. Prevalence and persistency of orthostatic blood pressure fall in older patients with isolated systolic hypertension. Syst-Eur Investigators. Journal of human hypertension 1996. link 3 Traub YM, Shapiro AP, Dujovny M, Nelson D. Cerebral blood flow changes with diuretic therapy in elderly subjects with systolic hypertension. Clinical and experimental hypertension. Part A, Theory and practice 1982. link 4 Gentzler RD, Gault JH, Liedtke AJ, McCann WD, Mann RH, Hunter AS. Congenital absence of the left circumflex coronary artery in the systolic click syndrome. Circulation 1975. link

    Original source

    1. [1]
      Carotid body resection for sympathetic modulation in systolic heart failure: results from first-in-man study.Niewinski P, Janczak D, Rucinski A, Tubek S, Engelman ZJ, Piesiak P et al. European journal of heart failure (2017)
    2. [2]
      Prevalence and persistency of orthostatic blood pressure fall in older patients with isolated systolic hypertension. Syst-Eur Investigators.Vanhanen H, Thijs L, Birkenhäger W, Bulpitt C, Tilvis R, Sarti C et al. Journal of human hypertension (1996)
    3. [3]
      Cerebral blood flow changes with diuretic therapy in elderly subjects with systolic hypertension.Traub YM, Shapiro AP, Dujovny M, Nelson D Clinical and experimental hypertension. Part A, Theory and practice (1982)
    4. [4]
      Congenital absence of the left circumflex coronary artery in the systolic click syndrome.Gentzler RD, Gault JH, Liedtke AJ, McCann WD, Mann RH, Hunter AS Circulation (1975)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG